I have also taken a tracking position around 1 month earlier keeping the fact that Birla OPUS entering into paint segment. It is currently down around 10% from my buying price. I have an opinion that although sales are not growing and remains stagnant from last few years, but intrinsic value of company is increased due to capex in pharma packaging sector.
They are facing some challenges in supplying paint bucket to one of the Birla OPUS plant due to unavailability of IML printing machines, which is why they are supplying to Birla OPUS from their other plant.
Pharma packaging is a key sector to watch as it can command higher ebita/kg. Will continue to track results and concall to have pulse of the business.
